Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), a leading global medical cannabis company, has announced its upcoming third quarter 2025 financial results conference call. The event is scheduled for Wednesday, February 5, 2025, at 8:00 a.m. Eastern Time (6:00 a.m. Mountain Time). The company will release its financial results before markets open on the same day.
The conference call will be hosted by Miguel Martin, Executive Chairman and CEO, and Simona King, CFO, and will include a question and answer session. Investors can access the webcast through the company's investor relations website.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), un'azienda leader globale nella cannabis medica, ha annunciato la sua prossima conference call sui risultati finanziari del terzo trimestre 2025. L'evento è programmato per mercoledì 5 febbraio 2025, alle 8:00 ora orientale (6:00 ora montana). L'azienda pubblicherà i risultati finanziari prima dell'apertura dei mercati nello stesso giorno.
La conference call sarà ospitata da Miguel Martin, Presidente Esecutivo e CEO, e Simona King, CFO, e includerà una sessione di domande e risposte. Gli investitori possono accedere al webcast attraverso il sito web delle relazioni con gli investitori dell'azienda.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), una empresa líder mundial en cannabis medicinal, ha anunciado su próxima conferencia telefónica sobre los resultados financieros del tercer trimestre de 2025. El evento está programado para el miércoles 5 de febrero de 2025, a las 8:00 a.m. hora del Este (6:00 a.m. hora de las Montañas). La empresa dará a conocer sus resultados financieros antes de la apertura de los mercados el mismo día.
La conferencia será presentada por Miguel Martin, Presidente Ejecutivo y CEO, y Simona King, CFO, e incluirá una sesión de preguntas y respuestas. Los inversores pueden acceder a la transmisión a través del sitio web de relaciones con inversores de la empresa.
아우로라 캐노비스(Aurora Cannabis) (NASDAQ: ACB) (TSX: ACB)는 세계적인 의학용 대마초 회사로서 2025년 3분기 재무 결과 발표 전화 회의를 곧 개최할 예정이라고 발표했습니다. 이 행사는 2025년 2월 5일 수요일, 동부 표준시 오전 8:00 (산악 표준시 오전 6:00)에 예정되어 있습니다. 회사는 같은 날 시장이 열리기 전 재무 결과를 발표할 것입니다.
전화 회의는 미겔 마르틴 이사회 의장 겸 CEO와 시모나 킹 CFO가 진행하며, 질문 및 답변 세션도 포함될 것입니다. 투자자들은 회사의 투자자 관계 웹사이트를 통해 웹캐스트에 접근할 수 있습니다.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), une entreprise mondiale de cannabis médical leader, a annoncé sa prochaine conférence téléphonique sur les résultats financiers du troisième trimestre 2025. L'événement est prévu pour le mercredi 5 février 2025, à 8h00 heure de l'Est (6h00 heure des Rocheuses). L'entreprise publiera ses résultats financiers avant l'ouverture des marchés le même jour.
La conférence sera animée par Miguel Martin, Président Exécutif et PDG, et Simona King, CFO, et comprendra une session de questions-réponses. Les investisseurs peuvent accéder au webcast via le site web des relations avec les investisseurs de l'entreprise.
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), ein führendes globales Unternehmen im Bereich medizinisches Cannabis, hat seine kommende Telefonkonferenz zu den finanziellen Ergebnissen des dritten Quartals 2025 angekündigt. Die Veranstaltung ist für Mittwoch, den 5. Februar 2025, um 8:00 Uhr Eastern Time (6:00 Uhr Mountain Time) angesetzt. Das Unternehmen wird seine finanziellen Ergebnisse noch vor Markteröffnung am selben Tag veröffentlichen.
Die Telefonkonferenz wird von Miguel Martin, dem Executive Chairman und CEO, sowie Simona King, CFO, geleitet und umfasst eine Frage- und Antwortsitzung. Anleger können über die Investor-Relations-Website des Unternehmens auf das Webcast zugreifen.
- None.
- None.
NASDAQ | TSX: ACB
Conference Call Details
DATE: | Wednesday, February 5, 2025 |
TIME: | 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time |
WEBCAST: |
Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both the medical and consumer markets across
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing for the release of the Company's fiscal 2025 Q3 financial statements and the conference call to discuss the results.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-third-quarter-2025-investor-conference-call-302357921.html
SOURCE Aurora Cannabis Inc.
FAQ
When will Aurora Cannabis (ACB) release its Q3 2025 earnings?
What time is Aurora Cannabis (ACB) Q3 2025 earnings call?
Who will host Aurora Cannabis (ACB) Q3 2025 earnings call?
Where can I access Aurora Cannabis (ACB) Q3 2025 earnings call?
